Omnicell, Inc. (OMCL) News
Track canonical SquawkNews coverage tagged to OMCL, Omnicell, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 4 indexed stories across 3 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
OMCL Q2 saw solid results, but reduced the low end of its FY26 product bookings guide @ KEYB
OMCL Q2 saw solid results, but reduced the low end of its FY26 product bookings guide @ KEYB
EQUITY | Jul 31, 2026, 11:01 AM UTC
L
Omnicell Raises FY2026 Adj EPS Guidance from $1.80-$2.00 to $2.15-$2.30 vs $1.94 Est; Narrows FY2026 Sales Guidance from $1.215B-$1.255B to
Omnicell (NASDAQ: OMCL ) raises FY2026 Adj EPS guidance from $1.80-$2.00 to $2.15-$2.30 vs $1.94 analyst estimate. Narrows FY2026 sales outlook from $1.215 billion-$1.255 billion to $1.225 billion-$1.245 billion vs $1.24
EARNINGS | Jul 30, 2026, 10:40 AM UTC
L
OMCL Omnicell RESULTS: Q2, Q2 REV $312M, Q2 ADJ EBITDA $67M, Q2 Net Income $24M, Q2 ADJ Net Income $44M, Omnicell Earnings Notes:, Outlook Q
OMCL Omnicell RESULTS: Q2, Q2 REV $312M, Q2 ADJ EBITDA $67M, Q2 Net Income $24M, Q2 ADJ Net Income $44M, Omnicell Earnings Notes:, Outlook Q3 ADJ EPS $0.35-0.43, Guides Q3 2026 REV $301M-$307M
EARNINGS | Jul 30, 2026, 10:32 AM UTC
L
Omnicell Appoints COO Nnamdi Njoku As President, Effective July 1
Omnicell, Inc. (NASDAQ: OMCL ) ("Omnicell" or the "Company"), a leading healthcare technology provider focused on empowering autonomous medication management, today announced that Nnamdi Njoku has been appointed Presiden
GEOPOLITICS | Jul 01, 2026, 12:16 PM UTC